{
  "id": 1767514465268,
  "title": "Temporal Artery Biopsy & GCA Investigations",
  "summary": "An exhaustive guide to the diagnostic accuracy of temporal artery biopsy (TAB) and ultrasound in Giant Cell Arteritis, featuring findings from the landmark TABUL study. This layout details sensitivity, specificity, clinical indications, and the essential risks required for informed patient consent.",
  "date": "2026-01-04T08:14:25.268Z",
  "data": {
    "title": "Temporal Artery Biopsy & GCA Investigations",
    "summary": "An exhaustive guide to the diagnostic accuracy of temporal artery biopsy (TAB) and ultrasound in Giant Cell Arteritis, featuring findings from the landmark TABUL study. This layout details sensitivity, specificity, clinical indications, and the essential risks required for informed patient consent.",
    "summary_illustration": "<svg viewBox='0 0 200 200' xmlns='http://www.w3.org/2000/svg'><circle cx='100' cy='100' r='80' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='4'/><path d='M60 100 Q80 60 100 100 T140 100' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='4'/><path d='M100 40 V160 M40 100 H160' stroke='hsl(215, 90%, 20%)' stroke-width='1' stroke-dasharray='4'/><rect x='85' y='85' width='30' height='30' fill='hsl(215, 90%, 45%)' opacity='0.2'/></svg>",
    "sections": [
      {
        "title": "The TABUL Study Findings",
        "icon": "biotech",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "blue",
        "content": [
          "The TABUL study found that for diagnosing GCA, clinical judgement (clinician’s assessment at 2wk) combined with a TAB showed sensitivity and specificity of 91% and 81%, respectively.",
          "Clinical judgement combined with duplex US showed sensitivity and specificity of 93% and 77%, respectively.",
          "The cost-effectiveness was found in favour of US.",
          "Reference: See Table 16.6 and Box 16.4."
        ]
      },
      {
        "title": "Table 16.6: Investigations in GCA - Histological",
        "icon": "microscope",
        "type": "table",
        "layout": "half_width",
        "color_theme": "green",
        "content": {
          "headers": [
            "Investigation",
            "Sensitivity",
            "Specificity"
          ],
          "rows": [
            [
              "TAB (unilateral)",
              "80– 90%",
              "100%"
            ],
            [
              "TAB (bilateral)",
              "95– 97%",
              "100%"
            ],
            [
              "TAB in TABUL§",
              "39%",
              "≤100%"
            ]
          ]
        }
      },
      {
        "title": "Table 16.6: Haematological Investigations",
        "icon": "bloodtype",
        "type": "table",
        "layout": "half_width",
        "color_theme": "purple",
        "content": {
          "headers": [
            "Marker (Study)",
            "Sensitivity",
            "Specificity"
          ],
          "rows": [
            [
              "iESR (Hayreh)*",
              "92%",
              "N/A"
            ],
            [
              "iCRP (Hayreh)*",
              "100%",
              "N/A"
            ],
            [
              "iESR + iCRP (Hayreh)*",
              "94%",
              "97%"
            ],
            [
              "iESR + iPlt (Foroozan)†",
              "51%",
              "91%"
            ]
          ]
        }
      },
      {
        "title": "Table 16.6: Imaging & Duplex US",
        "icon": "settings_remote",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Imaging Modality",
            "Sensitivity",
            "Specificity"
          ],
          "rows": [
            [
              "Characteristic ‘halo’ sign on Duplex US",
              "69%",
              "82%"
            ],
            [
              "US compared with biopsy-proven GCA‡",
              "55%",
              "94%"
            ],
            [
              "US compared with the ACR criteria‡",
              "N/A",
              "N/A"
            ],
            [
              "US in TABUL§",
              "54%",
              "81%"
            ]
          ]
        }
      },
      {
        "title": "Indication & Clinical Context",
        "icon": "info",
        "type": "plain_text",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": "Superficial TAB remains highly specific for the diagnosis of GCA (see E Arteritic AION and giant cell arteritis, pp. 744–6). Temporal artery biopsy 749."
      },
      {
        "title": "Consent: Procedure & Rationale",
        "icon": "assignment_turned_in",
        "type": "process",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Discuss what the procedure involves",
          "Discuss the rationale for the biopsy",
          "Discuss possible complications"
        ]
      },
      {
        "title": "Surgical Risks & Complications",
        "icon": "warning",
        "type": "red_flag",
        "layout": "full_width",
        "color_theme": "red",
        "content": [
          "Visible scarring (particularly if incision is pretrichial and not parallel to Langer’s lines).",
          "Haematoma.",
          "Wound infection.",
          "Scalp or skin necrosis.",
          "Facial nerve injury, with variable recovery (particularly if pretrichial incision).",
          "Biopsy does not include the temporal artery (up to 1.25% of specimens in one report were vein or peripheral nerve).",
          "Cerebral infarction (rare; possibly related to collateral blood flow to the brain from the superficial temporal artery)."
        ]
      },
      {
        "title": "Study References",
        "icon": "menu_book",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "purple",
        "content": "* Hayreh SS et al. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997;123:285– 96.\n† Foroozan R et al. Thrombocytosis in patients with biopsy- proven giant cell arteritis. Ophthalmology. 2002;109:1267– 71.\n‡ Karassa FB et al. Meta- analysis: test performance of ultrasonography for giant- cell arteritis. Ann Intern Med. 2005;142:359– 69.\n§ Luqmani R et al. The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost- effectiveness study. Health Technology Assessment No. 20.90. Southampton: NIHR Journals Library; 2016. Available at: M https:// www.ncbi.nlm.nih.gov/ books/ NBK401231/ . doi: 10.3310/ hta20900."
      }
    ]
  },
  "chapterId": "neuro",
  "seqId": 75
}